Showing results (1-10 of 23) with videos related to
Sort By:
Pageof 3
Cancer Research|February 15, 1991
Camptothecin, teniposide, or 4'-(9-acridinylamino)-3-methanesulfon-m-anisidide, but not mitoxantrone or doxorubicin, induces degradation of nuclear DNA in the S phase of HL-60 cellsG Del Bino, Z DarzynkiewiczExperimental Cell Research|March 1, 1991
The S-phase cytotoxicity of camptothecinG Del Bino, P Lassota, Z DarzynkiewiczCancer Research|September 15, 1990
Diverse effects of camptothecin, an inhibitor of topoisomerase I, on the cell cycle of lymphocytic (L1210, MOLT-4) and myelogenous (HL-60, KG1) leukemic cellsG Del Bino, J S Skierski, Z DarzynkiewiczExperimental Cell Research|August 1, 1991
The concentration-dependent diversity of effects of DNA topoisomerase I and II inhibitors on the cell cycle of HL-60 cellsG Del Bino, J S Skierski, Z DarzynkiewiczCytometry|November 1, 1981
DNA content and kinetic characteristics of non-Hodgkin's lymphoma: determined by flow cytometry and autoradiographyA Costa, G Mazzini, G Del Bino, et al.Leukemia|February 1, 1994
Altered susceptibility of differentiating HL-60 cells to apoptosis induced by antitumor drugsG Del Bino, X Li, F Traganos, et al.Cell and Tissue Kinetics|March 1, 1987
Implications of disaggregation procedures on biological representation of human solid tumoursA Costa, R Silvestrini, G Del Bino, et al.Cell Proliferation|November 1, 1992
Apoptotic cell death triggered by camptothecin or teniposide. The cell cycle specificity and effects of ionizing radiationG Del Bino, S Bruno, P N Yi, et al.Leukemia|November 1, 1992
Inhibitors of proteases prevent endonucleolysis accompanying apoptotic death of HL-60 leukemic cells and normal thymocytesS Bruno, G Del Bino, P Lassota, et al.Cell Biology International|April 25, 2000
Effect of the serine protease inhibitor N-tosyl-l-phenylalanine-chloromethyl ketone (TPCK) on MCF-7 mammary tumour cells growth and differentiationS Horman, G Del Bino, D Fokan, et al.Pageof 3